MEI Pharma, Inc.

Historical 13F Holders

Symbol
MEIP
CUSIP
55279B202
All holders as of
Q2 2023
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 55279B202 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Anson Funds Management LP 13D/A
3.7% 7/24/2025
Event 7/22/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q2 1 146 k $958 k
2023 Q1 52 48.8 M $11.2 M
2022 Q4 57 49.9 M $12.1 M
2022 Q3 65 47.6 M $18.4 M
2022 Q2 72 47.5 M $28.7 M
2022 Q1 98 56.5 M $34.5 M
2021 Q4 118 89.4 M $239 M
2021 Q3 110 65.2 M $180 M
2021 Q2 116 69.0 M $197 M
2021 Q1 113 70.8 M $243 M
2020 Q4 120 65.6 M $173 M
2020 Q3 111 66.1 M $206 M
2020 Q2 108 62.9 M $260 M
2020 Q1 85 64.6 M $104 M
2019 Q4 81 50.1 M $124 M
2019 Q3 74 36.9 M $62.0 M
2019 Q2 84 48.2 M $120 M
2019 Q1 66 41.0 M $126 M
2018 Q4 63 40.3 M $106 M
2018 Q3 68 36.4 M $157 M
2018 Q2 64 36.6 M $144 M
2018 Q1 48 8.69 M $18.0 M
2017 Q4 52 8.75 M $18.3 M
2017 Q3 59 8.64 M $23.2 M
2017 Q2 47 6.65 M $15.9 M
2017 Q1 48 6.35 M $10.3 M
2016 Q4 38 6.48 M $9.33 M
2016 Q3 43 5.82 M $10.2 M
2016 Q2 39 7.63 M $10.4 M
2016 Q1 41 9.94 M $12.5 M
2015 Q4 44 6.60 M $10.6 M
2015 Q3 40 6.22 M $9.76 M
2015 Q2 44 4.93 M $8.43 M
2015 Q1 54 7.98 M $14.4 M
2014 Q4 54 23.7 M $101 M
2014 Q3 39 12.8 M $88.3 M
2014 Q2 44 13.3 M $84.4 M
2014 Q1 53 14.7 M $164 M